lorazepam has been researched along with propranolol in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (31.43) | 18.7374 |
| 1990's | 5 (14.29) | 18.2507 |
| 2000's | 16 (45.71) | 29.6817 |
| 2010's | 3 (8.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrews, PR; Craik, DJ; Martin, JL | 1 |
| Coassolo, P; Lavé, T; Schneider, G | 1 |
| Strassburg, CP; Tukey, RH | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
| Abraham, MH; Acree, WE; Ibrahim, A | 1 |
| Artursson, P; Bergström, CA; Draheim, R; Holmén, AG; Wassvik, CM | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Sun, Y; Yan, Z | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Markomihelakis, H; Ogle, CW; Turner, P | 1 |
| Adler, L; Angrist, B; Corwin, J; Peselow, E; Rotrosen, J | 1 |
| Crouch, G; Hallstrom, C; Robson, M | 1 |
| Cerri, C; Cocco, E; Rovati, L | 1 |
| File, SE; Lister, RG | 1 |
| Ellison, JM | 1 |
| Muskin, PR | 1 |
| Huggett, T; Rutherford, D; Tyrer, P | 1 |
| Greenblatt, DJ; Ochs, HR; Verburg-Ochs, B | 1 |
| Ahlquist, J; Brown, MW; Rose, D | 1 |
| Jakobsson, J; Rane, K; Ryberg, G | 1 |
| Engelhardt, N; Greenblatt, DJ; Harmatz, JS; Scavone, JM; Shader, RI | 1 |
| Franco, P; López, P; Minguillón, C; Oliveros, L | 1 |
| Castronovo, V; Ferini-Strambi, L; Montorsi, F; Oldani, A; Rigatti, P; Smirne, S; Zucconi, M | 1 |
| Dimellis, D | 1 |
| Battegay, E; Gyr, N; Handschin, D; Martina, B; Zeller, A | 1 |
| Doig, K; Eliasziw, M; Kiss, ZH; Ranawaya, R; Suchowersky, O | 1 |
| Beversdorf, DQ; Bornstein, RA; Hughes, JD; Silver, JA | 1 |
| Billiot, E; Billiot, F; Warner, IM | 1 |
2 review(s) available for lorazepam and propranolol
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
8 trial(s) available for lorazepam and propranolol
| Article | Year |
|---|---|
The effects of high doses of oxprenolol and of propranolol on pursuit rotor performance, reaction time and critical flicker frequency.
Topics: Adult; Diazepam; Flicker Fusion; Humans; Lorazepam; Male; Motor Skills; Oxprenolol; Propranolol; Pulse; Reaction Time | 1976 |
Efficacy of propranolol in neuroleptic-induced akathesia.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Chronic Disease; Female; Humans; Lorazepam; Male; Middle Aged; Propranolol; Psychomotor Agitation; Random Allocation; Schizophrenia | 1985 |
A comparison of the effects of lorazepam with those of propranolol on experimentally-induced anxiety and performance.
Topics: Adult; Anxiety; Clinical Trials as Topic; Double-Blind Method; Emotions; Female; Humans; Lorazepam; Male; Propranolol; Psychomotor Performance; Pulse; Reaction Time; Stress, Psychological; Verbal Learning | 1985 |
Benzodiazepine withdrawal symptoms and propranolol.
Topics: Anti-Anxiety Agents; Diazepam; Humans; Lorazepam; Placebos; Propranolol; Substance Withdrawal Syndrome; Time Factors | 1981 |
Oral premedication one hour before minor gynaecological surgery--does it have any effect? A comparison between ketobemidone, lorazepam, propranolol and placebo.
Topics: Administration, Oral; Adolescent; Adult; Analgesics, Opioid; Double-Blind Method; Female; Humans; Lorazepam; Meperidine; Middle Aged; Preanesthetic Medication; Propranolol; Prospective Studies | 1995 |
Cognitive effects of beta-adrenergic antagonists after single doses: pharmacokinetics and pharmacodynamics of propranolol, atenolol, lorazepam, and placebo.
Topics: Adrenergic beta-Antagonists; Adult; Affect; Analysis of Variance; Atenolol; Cognition; Female; Humans; Lorazepam; Male; Mental Processes; Mental Recall; Propranolol; Reference Values | 1993 |
The Canadian multicenter trial of pallidal deep brain stimulation for cervical dystonia: preliminary results in three patients.
Topics: Amitriptyline; Botulinum Toxins; Cannabis; Combined Modality Therapy; Drug Therapy, Combination; Dysarthria; Electric Stimulation Therapy; Electrodes, Implanted; Feasibility Studies; Female; Globus Pallidus; Humans; Lactones; Lorazepam; Magnetic Resonance Imaging; Male; Middle Aged; Propranolol; Rhizotomy; Sulfones; Torticollis; Treatment Outcome | 2004 |
Effect of anxiolytics on cognitive flexibility in problem solving.
Topics: Administration, Oral; Adult; Anti-Anxiety Agents; Cognition; Creativity; Double-Blind Method; Female; Humans; Lorazepam; Male; Placebos; Problem Solving; Propranolol; Stress, Psychological | 2004 |
25 other study(ies) available for lorazepam and propranolol
| Article | Year |
|---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
Combining in vitro and in vivo pharmacokinetic data for prediction of hepatic drug clearance in humans by artificial neural networks and multivariate statistical techniques.
Topics: Animals; Biological Availability; Dogs; Humans; Least-Squares Analysis; Liver; Multivariate Analysis; Neural Networks, Computer; Pharmacokinetics; Rats | 1999 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
Molecular characteristics for solid-state limited solubility.
Topics: Chemical Phenomena; Chemistry, Physical; Molecular Structure; Multivariate Analysis; Pharmaceutical Preparations; Regression Analysis; Solubility | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
First-principle, structure-based prediction of hepatic metabolic clearance values in human.
Topics: Computational Biology; Drug Discovery; Hepatocytes; Humans; Hydrogen-Ion Concentration; Liver; Metabolic Clearance Rate; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship; Sensitivity and Specificity; Software | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Benzodiazepine dependent patients and their psychological treatment.
Topics: Adaptation, Psychological; Adult; Anti-Anxiety Agents; Behavior Therapy; Combined Modality Therapy; Diazepam; Female; Humans; Lorazepam; Male; Problem Solving; Propranolol; Psychotherapy, Group; Substance-Related Disorders | 1988 |
Propranolol and clonidine in detoxification.
Topics: Clonidine; Humans; Lorazepam; Methadone; Opioid-Related Disorders; Propranolol; Psychomotor Agitation | 1988 |
Emergency treatment of acute psychosis, agitation, and anxiety.
Topics: Anxiety Disorders; Diazepam; Droperidol; Emergencies; Haloperidol; Humans; Lorazepam; Panic; Propranolol; Psychomotor Agitation; Psychotic Disorders; Psychotropic Drugs | 1985 |
Panics, prolapse, and PVCs.
Topics: Adult; Anxiety Disorders; Arrhythmias, Cardiac; Diagnosis, Differential; Fear; Female; Humans; Imipramine; Lorazepam; Male; Middle Aged; Mitral Valve Prolapse; Panic; Propranolol | 1985 |
Propranolol interactions with diazepam, lorazepam, and alprazolam.
Topics: Adolescent; Adult; Alprazolam; Benzodiazepines; Biotransformation; Chromatography, High Pressure Liquid; Diazepam; Drug Interactions; Female; Humans; Injections, Intravenous; Kinetics; Lorazepam; Male; Nordazepam; Propranolol | 1984 |
Amnesia-producing drugs affect hippocampal frequency potentiation.
Topics: Amnesia; Animals; Evoked Potentials; Hippocampus; Humans; Lorazepam; Propranolol; Rats; Scopolamine | 1983 |
Bonded cellulose-derived high-performance liquid chromatography chiral stationary phases. I. Influence of the degree of fixation on selectivity.
Topics: Cellulose; Chemical Phenomena; Chemistry, Physical; Chromatography, High Pressure Liquid; Lorazepam; Magnetic Resonance Spectroscopy; Molecular Structure; Propranolol; Protein Structure, Secondary; Solubility; Stereoisomerism | 1996 |
Sleep-related painful erections: clinical and polysomnographic features.
Topics: Adrenergic beta-Antagonists; Adult; Amitriptyline; Humans; Lorazepam; Male; Middle Aged; Narcolepsy; Paroxetine; Penile Erection; Polysomnography; Propranolol; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Sexual Dysfunctions, Psychological; Sleep Stages; Sleep, REM | 1996 |
Serotonin syndrome produced by a combination of venlafaxine and mirtazapine.
Topics: Adrenergic beta-Antagonists; Adult; Antidepressive Agents, Tricyclic; Cyclohexanols; Drug Therapy, Combination; Female; Humans; Lorazepam; Mianserin; Mirtazapine; Propranolol; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Venlafaxine Hydrochloride | 2002 |
Blood pressure and heart rate of students undergoing a medical licensing examination.
Topics: Adrenergic beta-Antagonists; Adult; Antidepressive Agents; Anxiety; Blood Pressure; Educational Measurement; Female; Ginkgo biloba; Heart Rate; Humans; Hypertension; Licensure, Medical; Lorazepam; Male; Plant Extracts; Propranolol; Prospective Studies; Stress, Psychological; Students, Medical; Valerian; Vitamins | 2004 |
Optimization of 12 chiral analytes with 8 polymeric surfactants.
Topics: Alprenolol; Amino Acids; Benzodiazepinones; Buffers; Diamines; Electrophoresis, Capillary; Hydrogen-Ion Concentration; Lorazepam; Naphthalenes; Naphthols; Organophosphates; Oxazepam; Oxprenolol; Propanolamines; Propranolol; Stereoisomerism; Surface-Active Agents; Temazepam | 2008 |